PEPFAR Plans for Initiating ART and Providing Laboratory Services Tedd V. Ellerbrock, MD, FACOG Global AIDS Program Centers for Disease Control and Prevention.

Slides:



Advertisements
Similar presentations
UNDP RBA Workshop on MDG-Based National Development Strategies Module 4: Health Strategies UN Millennium Project February 27-March 3, 2006.
Advertisements

Lesotho Know Your Status (KYS) Campaign Plan Leave no Mosotho out.....every life counts! Universal Access to HIV Testing and Counselling in.
Group III: Demand Forecasting
Karin Weyer WHO Stop TB Department Stop TB Partnership Global Laboratory Initiative.
TB/HIV Integration What it entails Frank Lule, Eyerusalem Negussie, Reuben Granich, Haileyesus Getahun.
Improving diagnosis TB laboratory strengthening.
The Global Laboratory Initiative Assisting countries to implement the WHA resolution on MDR-TB Karin Weyer, WHO-STB, GLI secretariat John Ridderhof, CDC,
Implementation of Diagnostics in Resource-Limited Settings Amy Piatek Global Health Bureau, Office of Health, Infectious Diseases & Nutrition U.S. Agency.
Part A/Module A1/Session 4 Part A: Module A1 Session 4 Comprehensive Care for People Living with HIV/AIDS (PLHA)
EMTCT Tanzania Experience 6 th Joint Biennial HIV & AIDS Sector Review Dr MD Kajoka PMTCT Coordinator.
Guidance for Year 06 Track 1.0 ART Program Continuation Applications Tedd Ellerbrock, MD Team Leader, HIV Care and Treatment, GAP, CDC Barbara Aranda-Naranjo,
Presentation to the 2014 International AIDS Conference
Update: National AIDS Programmes FHI, Horizons, HHS-CDC & HRSA, Macro, Measure, Synergy, USAID, WHO,UNAIDS Katherine Marconi, Ph.D., MS Presenter A Guide.
Hepatitis and Liver Cancer A National Strategy for Prevention and Control of Hepatitis B and C.
HIV Prevention in a Military Setting
Module 1: Course Overview. Course Objectives Teach you everything you need to know about the TB Program Describe TB the roles and responsibilities of.
Possible solution: Change testing & care for patients in TB treatment Old system TB patient treated at TB center Referred to VCT center for HIV testing.
Accelerating TB/HIV activities in Zambia Alwyn Mwinga 2007 HIV Implementers Meeting 20 June 2007.
Treatment Optimization in Latin America and the Caribbean: How can the GF contribute?
MDR-TB: a fight we cannot afford to lose! Alexander Golubkov, MD, MPH Senior TB Technical Advisor.
Creating an AIDS-Free Generation The beginning of the end of AIDS Center for Strategic & International Studies Washington, DC March 22, 2012 Thomas R.
HIV Therapy for the Developing World: A Global Health Challenge Harold W. Jaffe, MD Department of Public Health University of Oxford Oxford, UK.
Global Response to HIV/AIDS Nigerian Nurses Association of USA June 30, 2006 Carolyn M Hall, MSN/MPH, ACRN Global HIV/AIDS Program U.S. Department of Health.
Tajikistan The Global Fund to Fight AIDS, Tuberculosis and Malaria Support to the Strategic Plan to Prevent HIV/AIDS Epidemics in Tajikistan. November.
Morbidity Monitoring Project Data for Resource Planning and Evaluation A.D. McNaghten Centers for Disease Control and Prevention.
Unit 1: Overview of HIV/AIDS Case Reporting #6-0-1.
The President’s Emergency Plan for AIDS Relief Next Generation Indicators.
10 Recommendations to Help Strengthen and Expand HIV Care and Treatment Services during the Next 12 Months Adult Treatment Technical Workgroup US Office.
ART Program of the HIV Vaccine Trials Network Margaret Wecker, PhD Associate Director, Scientific Operations and Business Development.
ASCP & Global Outreach. ASCP would like to thank the following for their support and interest: 2 The Center for Disease Control & Prevention– Central.
Group Discussion Guyana, The Bahamas T & T, Jamaica Barbados, Haiti Suriname, Curacao.
JNB/05 HIV/AIDS treatment - challenges in a remote rural area of Tanzania. Johan N. Bruun Department of Infectious Diseases Ullevål University Hospital.
MDG Needs Assessment Training Workshop May 9-12, 2005 Health Module.
The Strategic Use of ARVs | IAC Satellite, July 22, |1 | Strategic Use of Antiretroviral Drugs WHO Perspective for Future Guidelines Chair of WHO.
1 HIV/AIDS Related Research Agenda Workshop Phnom Penh, Sunway Hotel March 28-29, 2007.
Our vision: Healthier communities, Excellence in healthcare Our values: Teamwork, Honesty, Respect, Ethical, Excellence, Caring, Commitment, Courage DOTS.
2013 WHO Consolidated ARV Guidelines Summary of Major Recommendations and Estimated Impact GSG Briefing July 19, 2013 Gottfried Hirnschall, Director HIV.
Office of Overseas Programming & Training Support (OPATS) Treatment Adherence HIV Care, Support, and Treatment.
Resource Needs Model Rachel Sanders October 28 th, 2010.
HIV/AIDS IN PERU. Map General statistics Population million Life expectancy: Male: years Female: 75.6 years GNI billion Literacy.
Improving access to HIV testing and other basic health services in rural areas of Malawi through mobile clinics E.S. Schell, RN, PhD, FAAN; A. Bvumbwe,
Downloaded from Current Status of ART Opportunities & Challenges Kibrebeal Melaku,MD Associate Professor.
PEPFAR Scenario –based Cost Projections for PEPFAR Resource Requirements for the ART Program in Ethiopia from FY2011 – FY2015 Solomon Ahmed, M.D. Technical.
Case 8 38 year-old man from Sub-Saharan Africa Came to UK in 2001 Living in London First wife died 10 years ago of TB Remarried for 7 years, wife currently.
The WHO HIV Drug Resistance Strategy Presented by Dr. Don Sutherland Prepared by: Dr. Don Sutherland Dr Silvia Bertagnolio Dr Diane Bennett HIV Drug Resistance.
Fifth Annual President’s Emergency Plan for AIDS Relief Track 1.0 ART Program Meeting September , 2007 Thomas J. Spira, M.D. International Laboratory.
I NSIGHTS INTO HIV C ARE S ERVICE C OMPREHENSIVENESS AND L ABORATORY C APACITY AT ICAP- SUPPORTED F ACILITIES : F INDINGS FROM PF A CTS 2013 Caitlin Madevu-Matson.
‘Gaps in the global HIV/AIDS success story Copenhagen December 2 nd 2013 Gaps in the global HIV/AIDS success story Briefing on HIV/AIDS in Europe Martin.
President’s Emergency Plan for AIDS Relief 2006 Semi-Annual Program Results (SAPR) October 1, 2005 – March 31, 2006.
Philippe Chiliade, MD, MHA Technical Advisor, Clinical Care, FHI 12 August 2008 Family Health International Implementing HIV Care & Treatment Progress.
Annual Epidemiological Spotlight on HIV in London: 2014 data Field Epidemiology Services PHE Publications gateway number
Mövenpick Royal Palm Hotel Dar es Salaam, Tanzania August 4-6, 2009 The 7th Annual Track 1.0 ART Program Meeting.
Scaling-up HIV Prevention, Care and Antiretroviral Therapy at Primary Health Centers A WHO/PEPFAR Collaboration.
HIV Testing for TB Patients in the Context of ART Scale-Up - Barriers to Implementation Kevin M. De Cock, MD CDC Kenya Geneva, February 14, 2005.
Investing in Different Models of Local Ownership to Ensure Sustainable Patient Care Track 1 Implementers Meeting Maputo, Mozambique August
World Vision Experiences in Making ART Treatment Affordable and Available Dr. Daniel J Malleboyina M.B.B.S, MBA, MPH Regional Advisor HIV & AIDS- Asia.
Global Fund: Contributions to the Global Health Workforce 2 – 3 February 2012 Irish Forum for Global Health Conference.
Fast-Tracking Treatment to End AIDS ICASA Ambassador Deborah Birx, MD U.S. Global AIDS Coordinator November 30, 2015.
ARV Treatment Scale Up: Progress in Ukraine Andriy Klepikov Executive Director, International HIV/AIDS Alliance in Ukraine ARV Treatment Scale Up: Progress.
11 Laboratory Quality Improvement for clinical HIV/AIDS Services in the Uniformed Forces Mwaibako, J, Shija, L; Haverkamp, G; van den Hombergh; Katebalila,
Gap Analysis: Tuberculosis Care in Malawi Round 11 proposal to the Global Fund to Fight AIDS, Tuberculosis and Malaria Africa 3: Team Malawi Arianna, Babatunde,
TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.
Thailand experience in implementing collaborative HIV/TB activities Anupong Chitwarakorn, MD Ministry of Public Health, Thailand TB/HIV Satellite symposium.
The HIV Response Where are we now?
Zimbabwe’s shift towards treat all: national country context
This is an archived document.
Pre-conference Meeting Report
Tuberculosis and the President’s Emergency Plan for AIDS Relief
The Global Fund to Fight AIDS, Tuberculosis and Malaria
TB Screening and Differentiated Service Delivery: State of the Art
Presentation transcript:

PEPFAR Plans for Initiating ART and Providing Laboratory Services Tedd V. Ellerbrock, MD, FACOG Global AIDS Program Centers for Disease Control and Prevention

Goals of PEPFAR During a 5-year period, the goals of PEPFAR are To treat at least 2 million HIV-infected people with antiretroviral therapy (ART) To prevent 7 million new HIV infections, which is about 60% of the projected new infections in the 14 participating countries To care for 10 million HIV-affected individuals and AIDS orphans

Goals of PEPFAR During a 5-year period, the goals of PEPFAR are: To treat at least 2 million HIV-infected people with antiretroviral therapy (ART) To prevent 7 million new HIV infections, which is about 60% of the projected new infections in the 14 participating countries To care for 10 million HIV-affected individuals and AIDS orphans

PEPFAR Plans for Initiating ART and Providing Laboratory Services If we plan to initiate ART and provide lab services for 2 million HIV-infected persons, we need to address several important questions and develop a consensus about what are the best answers to these questions

Questions that Need to be Answered to Initiate ART for 2 Million Persons Question #1 What are the major factors that will determine how many HIV- infected persons will be treated through PEPFAR?

Major Factors that will Determine How Many HIV- infected Persons will be Treated through PEPFAR Goal of PEPFAR – treat at least 2 million with ART Funding of PEPFAR – $10 billion over 5 years Need – 20 million HIV-infected persons live in the 14 PEPFAR countries and at least 3 million (15%) of these qualify for ART Feasibility – if we receive the funding, determining how many persons we can feasibly treat with ART will probably not be an option because those who are not treated are at risk of serious illness and death

Major Factors that will Determine How Many HIV- infected Persons will be Treated through PEPFAR Goal of PEPFAR – treat at least 2 million with ART Funding of PEPFAR – $10 billion over 5 years Need – 20 million HIV-infected persons live in the 14 PEPFAR countries and at least 3 million (15%) of these qualify for ART Feasibility – if we receive the funding, determining how many persons we can feasibly treat with ART will probably not be an option because those who are not treated are at risk of serious illness and death

Questions that Need to be Answered to Initiate ART for 2 Million Persons Question #1 What are the major factors that will determine how many HIV- infected persons will be treated through PEPFAR? Response The major factors that will determine how many persons will be treated through PEPFAR are probably the goals of PEPFAR, the funding for PEPFAR, and the need for ART; stating that a goal is not feasible may not be an option.

Questions that Need to be Answered to Initiate ART for 2 Million Persons Question #2 If we initiate ART for 2 million persons during the next 5 years, how many persons should we start on ART during the first year of PEPFAR?

Number of HIV-infected Persons Who Need to be Started on ART Annually during the Next 5 Years

200,000 – during the first year 300,000 – during the second year 400,000 – during the third year 500,000 – during the fourth year 600,000 – during the fifth year 2,000,000 – total during 5 years

Questions that Need to be Answered to Initiate ART for 2 Million Persons Question #2 If we initiate ART for 2 million persons during the next 5 years, how many persons should we start on ART during the first year of PEPFAR? Response If we initiate ART for 2 million persons during the next 5 years, we estimate that about 200,000 will have to be started on ART during the first year of PEPFAR

Questions that Need to be Answered to Initiate ART for 2 Million Persons Question #3 How can we initiate ART for 200,000 HIV-infected persons during the first year of PEPFAR?

Plan for Initiating ART for 200,000 Persons during First Year of PEPFAR Need to address issues related to: Clinical care Drugs and health commodities Laboratory support Training Community mobilization Monitoring and evaluation

Plan for Initiating ART for 200,000 Persons during First Year of PEPFAR For laboratory support, we need to decide which of the following services we can provide: HIV diagnostics Hematology Chemistries CD4+ counts Viral loads Diagnosis of OIs Diagnosis of malaria Diagnosis of TB Diagnosis of STIs Pediatric HIV diagnostics

Plan for Initiating ART for 200,000 Persons during First Year of PEPFAR For each laboratory service, we need to need to address issues related to: Training Infrastructure Equipment and supplies Quality assurance Information systems

Questions that Need to be Answered to Initiate ART for 2 Million Persons Question #3 How can we initiate ART for 200,000 HIV-infected persons during the first year of PEPFAR? Response To initiate ART for 200,000 HIV-infected persons during the first year of PEPFAR, we will probably have to provide only essential laboratory services in at least some settings

Questions that Need to be Answered to Initiate ART for 2 Million Persons Question #4 What laboratory services are essential for initiating ART for 200,000 persons during the first year of PEPFAR?

Plan for Initiating ART for 200,000 Persons during First Year of PEPFAR Essential Laboratory Services for the First Year of PEPFAR (in order of priority)  HIV diagnostics  Diagnosis of TB  Diagnosis of malaria  CD4+ counts  Chemistries

Plan for Initiating ART for 200,000 Persons during First Year of PEPFAR Essential Laboratory Services for Large Urban Hospitals during the First Year of PEPFAR  HIV diagnostics  Diagnosis of TB  Diagnosis of malaria  CD4+ counts

Plan for Initiating ART for 200,000 Persons during First Year of PEPFAR Essential Laboratory Services for District Hospitals during the First Year of PEPFAR  HIV diagnostics  Diagnosis of TB  Diagnosis of malaria

Questions that Need to be Answered to Initiate ART for 2 Million Persons Question #4 What laboratory services are essential for initiating ART for 200,000 persons during the first year of PEPFAR? Response In some settings, diagnostics for HIV, TB, and malaria may be the only laboratory services that we can provide during the first year of PEPFAR

Questions that Need to be Answered to Initiate ART for 2 Million Persons Question #5 How can we develop a strategic plan for laboratory services during the first year of PEPFAR?

Strategic Plan for Laboratory Services during the First Year of PEPFAR For the services listed below, we could suggest objectives for each of 2 types of clinical settings (for example, for large urban and district hospitals) and make recommendations about how best to achieve these objectives: HIV diagnostics Hematology Chemistries CD4+ counts Viral loads Diagnosis of OIs Diagnosis of malaria Diagnosis of TB Diagnosis of STIs Pediatric HIV diagnostics

Strategic Plan for Laboratory Services during the First Year of PEPFAR During this meeting, the work groups could develop first year objectives for 2-3 services for 2 types of clinical settings and make recommendations about how best to achieve these objectives The objectives and recommendations could be reviewed and discussed during the work group presentations on the second day of the meeting After the meeting, the objectives and recommendations could be compiled into a strategic plan for providing laboratory services during the first year of PEPFAR

Questions that Need to be Answered to Initiate ART for 2 Million Persons Question #5 How can we develop a strategic plan for laboratory services during the first year of PEPFAR? Response We can use the work groups during this meeting to develop a strategic plan for laboratory services during the first year of PEPFAR

Questions that Need to be Answered to Initiate ART for 2 Million Persons Question #6 How can we help to implement a strategic plan for laboratory services during the first year of PEPFAR?

Strategic Plan for Laboratory Services during the First Year of PEPFAR By March 31, 2004, USG staff in each PEPFAR country has been asked to submit a country plan for the first year of PEPFAR In consultation with in-country USG staff, we could organize a lab team to assist each PEPFAR country prepare the country plan for laboratory sevices for the first year of PEPFAR The lab teams could use the strategic lab plan for the first year, developed initially at this meeting, as guidance when preparing the country plans

GAP Laboratory Support Structure Steering Committee T. Mastro, S. Wiktor, A.Demby, P. Crippen – GAP R. Martin, T. Hearn, J. Ridderhof – PHPPO M. Rayfield, J. Kaplan, R. Ballard, S. McDougal – DASTLR Yvette Benjamin - APHL APHL GAP country-specific lab liaison team Laboratory Technical Advisory Group CDC/CIOs, Lab Leaders in GAP countries, WHO DASTLR PHPPO GAP country STI Lab Sys Dx Surv Dx Care QATB Technical Working Groups OI UTAP

COUNTRYLaboratory Points of Contact BotswanaThomas Hearn, DLS/PHPPO Cote d’IvoireAustin Demby, GAP EthiopiaRobert Martin, DLS/PHPPO GuyanaThomas Hearn, DLS/PHPPO HaitiRichard Respess, DASTLR KenyaMark Rayfield, DASTLR MozambiqueAmilcar Tanuri, DASTLR NamibiaAustin Demby, GAP NigeriaMark Rayfield, DASTLR RwandaAustin Demby, GAP South AfricaRon Ballard, DASTLR TanzaniaThomas Hearn, DLS/PHPPO UgandaAustin Demby, GAP ZambiaJohn Ridderhof, DLS/PHPPO CDC Lab Points of Contact by Country

Questions that Need to be Answered to Initiate ART for 2 Million Persons Question #6 How can we help to implement a strategic plan for laboratory services during the first year of PEPFAR? Response We can help implement a strategic plan for laboratory services during the first year of PEPFAR by using lab teams to help countries prepare their country plans for the first year during January – March 2004

Summary To treat at least 2 million HIV-infected people with ART during 5 years, we will probably need to initiate ART for about 200,000 persons during the first year of PEPFAR To initiate ART for 200,000 persons during the first year, we need to develop plans for providing laboratory services during the first year of PEPFAR This meeting offers a unique opportunity to begin preparing a strategic laboratory plan that can be used to prepare country plans for the first year of PEPFAR